Brian Mann
Stories
-
Ukraine's counteroffensive gains traction in the south
Ukraine has made significant progress but at great cost, and the terrain ahead is heavily defended.
-
Rural voters shaping the GOP presidential primary turn against U.S. aid to Ukraine
Populist politicians and right-wing media have convinced many voters that U.S. aid for Ukraine is a waste of money. Domestic problems should take precedent, they say.
-
Supreme Court temporarily blocks $6 billion Purdue Pharma-Sackler bankruptcy
Supreme Court's decision to review the controversial bankruptcy deal involving the maker of Oxycontin means the settlement will remain on hold at least through December.
-
Only 1 in 5 people with opioid addiction get the medications to treat it, study finds
Overdose deaths from fentanyl and other opioids have surged but medications that could save thousands of lives "are sitting on the shelf unused," according to new research.
-
Trail running through the Tallgrass Prairie National Preserve in Kansas
The tallgrass prairie is an astonishing place to run — rolling hills, bison herds, wildflowers and birds moving along the creeks. We take a run in the Tallgrass Prairie National Preserve in Kansas.
-
Overdose deaths involving street xylazine surged years earlier than reported
A new report from the Centers for Disease Control and Prevention found U.S. deaths involving xylazine, known on the street as Tranq, had already risen 35-fold by 2021.
-
Family members backed the $500,000 bond that freed Rep. Santos from jail
For weeks New York's embattled Republican congressman fought to keep the backers of his bond secret. Turns out it was his dad and his aunt.
-
The missing submersible raises troubling questions for the adventure tourism industry
The search for the Titan in the North Atlantic continues. When adventure travel goes wrong, who pays the price, and who's forced to take big risks mounting a rescue?
-
A dangerous chemical Xylazine is being added to U.S. street drugs, killing thousands
Public health and law enforcement agencies around the U.S. are scrambling to blunt the impact of xylazine, a deadly new threat to Americans who use street drugs.
-
Drug-maker Mallinckrodt may renege on $1.7 billion opioid settlement
Victims of prescription opioid addiction as well as communities slammed by the opioid crisis could wind up with nothing if Mallinckrodt files for a second bankruptcy.